Specifically, CCNA2 showed an odds ratio (OR) of 2.024 (95% confidence interval [CI]: 1.078–3.803; P = 0.028), suggesting its potential importance in the development of NSCLC and warranting further investigation. This evidence concerns the gene CCNA2 and non-small cell lung carcinoma.